The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
News and media menu
Published date
- March 2025 (1)
- December 2024 (2)
- November 2024 (1)
- September 2024 (1)
- August 2024 (1)
- July 2024 (1)
- May 2024 (1)
- March 2024 (1)
- February 2024 (1)
- January 2024 (1)
- December 2023 (3)
- November 2023 (2)
- September 2023 (2)
- August 2023 (2)
- July 2023 (1)
- June 2023 (1)
- March 2023 (2)
- December 2022 (3)
- November 2022 (1)
- July 2022 (1)
- December 2021 (1)
- August 2021 (1)
- July 2021 (1)
- June 2021 (1)
- April 2021 (1)
- February 2021 (1)
- December 2020 (1)
- November 2020 (2)
- October 2020 (2)
- September 2020 (1)
- July 2020 (1)
- June 2020 (1)
- May 2020 (1)
- January 2020 (3)
- December 2019 (1)
- September 2019 (1)
- August 2019 (1)
- June 2019 (2)
- April 2019 (1)
- March 2019 (1)
- December 2018 (2)
- October 2018 (1)
- July 2018 (1)
- May 2018 (1)
- March 2018 (1)
- January 2018 (2)
- October 2017 (1)
- August 2017 (2)
- June 2017 (5)
- May 2017 (2)
- April 2017 (1)
- March 2017 (1)
- February 2017 (1)
- December 2016 (1)
- October 2016 (2)
- September 2016 (1)
- August 2016 (1)
- July 2016 (1)
Search
81 result(s) found, displaying 51 to 75
- AACMC meeting 9, 14 March 2019The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #9.
- AACMC meeting 8, 28 November 2018The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #8.
- Medicinal cannabis process clarification - from cultivation to manufactureA clarification of the processing rules around the timing of a medicinal cannabis licence and narcotics manufacturing licences.
- Review of the Narcotic Drugs Act 1967 (2019)Professor John McMillan AO appointed to review and report on the operation of the Narcotic Drugs Act 1967.
- Review of the Narcotic Drugs Act 1967 - Public meetingsThe TGA will be hosting public meetings in February 2019 in Sydney, Brisbane and Melbourne.
- Correcting the record: Australian Financial Review story on medicinal cannabisCorrecting the record on the 5 December 2016 Australian Financial Review story.
- AACMC meeting 7, 9 August 2018The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #7.
- AACMC meeting 6, 10 May 2018The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communique #6.
- Claims about hemp and CBD oils misleading consumersFalse and misleading claims made by some companies
- AACMC meeting 5, 7 February 2018The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communique #5.
- AACMC meeting 4, 12 December 2017The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communique #4.
- Export of medicinal cannabis and other changes to the Narcotic Drugs Regulation 2016Allowing the export of Australian-manufactured medicinal cannabis products.
- AACMC meeting 3, 14 September 2017The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communique #3.
- Message to the medical profession and patients: Office of Drug Control is not blocking imports of medicinal cannabis products.Doctors wishing to prescribe unregistered medicinal cannabis products under SAS Cat A.
- Update: Export of Australian cultivated and manufactured medicinal cannabis productsResponse to public consultation is now available.
- Export of Australian cultivated and manufactured medicinal cannabis productsOffice of Drug control is seeking feedback on the potential export of medicinal cannabis.
- AACMC meeting 2, 7 June 2017The Australian Advisory Council on the Medicinal Use of Cannabis, Communique #2.
- Industry information and consultation sessions on medicinal cannabis - Adelaide and Brisbane - July 2017The Office of Drug Control will be hosting two information and consultation sessions in July 2017.
- Supply of medicinal cannabis product under the Narcotic Drugs Act 1967Imported medicinal cannabis products only, not domestically produced product, can now be supplied through Special Access Scheme Category A.
- Medicinal cannabis products: Special Access Scheme Category AUnregistered medicinal cannabis products can now be prescribed under the Special Access Scheme Category A.
- Progress update of licence applications and approvals43 licence applications under assessment and 7 already approved.
- AACMC meeting 1, 7 April 2017The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communique #1.
- The Office of Drug Control grants first commercial medicinal cannabis licenceThe first commercial medicinal cannabis licence has been granted, giving doctors greater treatment choices.
- Office of Drug Control grants first cannabis licenceOn Friday 17 February 2017, the Office of Drug control issued the very first licence under the medicinal cannabis provisions of the Narcotic Drugs Act 1967.